ATE445416T1 - Topische wasser-und ethanolfreie pimecrolimus enthaltende zusammensetzungen - Google Patents

Topische wasser-und ethanolfreie pimecrolimus enthaltende zusammensetzungen

Info

Publication number
ATE445416T1
ATE445416T1 AT03787785T AT03787785T ATE445416T1 AT E445416 T1 ATE445416 T1 AT E445416T1 AT 03787785 T AT03787785 T AT 03787785T AT 03787785 T AT03787785 T AT 03787785T AT E445416 T1 ATE445416 T1 AT E445416T1
Authority
AT
Austria
Prior art keywords
free
pimecrolimus
ethanol
compositions containing
containing water
Prior art date
Application number
AT03787785T
Other languages
English (en)
Inventor
Dorothea Ledergerber
Jean-Claude Sonntag
Katrin Kriwet
Nabila Sekkat
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE445416T1 publication Critical patent/ATE445416T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT03787785T 2002-08-14 2003-08-13 Topische wasser-und ethanolfreie pimecrolimus enthaltende zusammensetzungen ATE445416T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0218996.7A GB0218996D0 (en) 2002-08-14 2002-08-14 Organic compounds
PCT/EP2003/008999 WO2004016289A1 (en) 2002-08-14 2003-08-13 Topical anhydrous and ethanol-free ascomycin compositions

Publications (1)

Publication Number Publication Date
ATE445416T1 true ATE445416T1 (de) 2009-10-15

Family

ID=9942370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03787785T ATE445416T1 (de) 2002-08-14 2003-08-13 Topische wasser-und ethanolfreie pimecrolimus enthaltende zusammensetzungen

Country Status (23)

Country Link
US (1) US20050220850A1 (de)
EP (1) EP1534339B1 (de)
JP (1) JP2005537302A (de)
KR (1) KR100624583B1 (de)
CN (1) CN1674940A (de)
AR (1) AR040859A1 (de)
AT (1) ATE445416T1 (de)
AU (1) AU2003258607B2 (de)
BR (1) BR0313462A (de)
CA (1) CA2495345A1 (de)
DE (1) DE60329687D1 (de)
EC (1) ECSP055597A (de)
GB (1) GB0218996D0 (de)
IL (1) IL166601A0 (de)
MX (1) MXPA05001767A (de)
NO (1) NO20051232L (de)
NZ (1) NZ538138A (de)
PE (1) PE20040330A1 (de)
PL (1) PL373230A1 (de)
RU (1) RU2343919C2 (de)
TW (1) TW200410713A (de)
WO (1) WO2004016289A1 (de)
ZA (1) ZA200500815B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US9168224B2 (en) * 2004-04-08 2015-10-27 Meda Pharma Sarl Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
US20080207670A1 (en) * 2004-09-16 2008-08-28 Bayer Healthcare Ag Dermally Applicable Formulations For Treating Skin Diseases in Animals
GB0425255D0 (en) * 2004-11-16 2004-12-15 Novartis Ag Pharmaceutical composition
DE102005037844A1 (de) * 2005-08-04 2007-04-05 Intendis Gmbh Wasserfreies Mehr-Phasen-Gel-System
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
WO2008063563A2 (en) 2006-11-16 2008-05-29 Transderm, Inc. Methods of treating keratin hyperproliferation disorders using mtor inhibitors
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
DK2948134T3 (da) 2013-01-24 2020-06-02 Palvella Therapeutics Inc Sammensætninger til transdermal indgivelse af mtor-inhibitorer
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
FR3061009B1 (fr) 2016-12-22 2020-09-25 Oreal Composition cosmetique comprenant une ou plusieurs huile(s) polaire(s), un monoalcool aliphatique en c2-c6 et un polyol, au moins un actif hydrophile, et comprenant moins de 7% en poids d’eau
FR3061008B1 (fr) * 2016-12-22 2020-05-01 L'oreal Composition cosmetique comprenant une ou plusieurs huile(s) polaire(s), un monoalcool aliphatique en c2-c6 et un polyol, et comprenant moins de 5% en poids d’eau
IL267869B2 (en) * 2017-01-06 2023-10-01 Palvella Therapeutics Inc Non-aqueous preparations of mTOR inhibitors and methods of use
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
FR3104962B1 (fr) * 2019-12-20 2021-12-31 Oreal Composition cosmétique comprenant au moins une huile polaire, un monoalcool aliphatique, un mélange de polyols et au moins un actif hydrophile
CN116602914B (zh) * 2023-07-05 2024-02-13 江苏知原药业股份有限公司 一种皮炎用乳膏及其生产工艺及其生产设备

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
DE69125230T2 (de) * 1990-09-04 1997-07-10 Fujisawa Pharmaceutical Co Tricyclische Verbindungen enthaltende Salben
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
ATE246909T1 (de) * 1994-03-07 2003-08-15 Theratech Inc Medikament enthaltende, adhesive, zusammenbaubare,transdermale abgabevorrichtung
CN1089233C (zh) * 1994-10-26 2002-08-21 诺瓦蒂斯有限公司 药物组合物
GB2327610B (en) * 1994-11-04 1999-06-02 Novartis Ag Macrolide compositions
ID29262A (id) * 1998-04-27 2001-08-16 Fujisawa Pharmaceutical Co Komposisi farmasi
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
KR20050042475A (ko) 2005-05-09
GB0218996D0 (en) 2002-09-25
US20050220850A1 (en) 2005-10-06
PL373230A1 (en) 2005-08-22
MXPA05001767A (es) 2005-04-25
DE60329687D1 (de) 2009-11-26
PE20040330A1 (es) 2004-07-15
EP1534339B1 (de) 2009-10-14
ZA200500815B (en) 2006-07-26
CN1674940A (zh) 2005-09-28
AU2003258607A1 (en) 2004-03-03
AU2003258607B2 (en) 2007-01-04
CA2495345A1 (en) 2004-02-26
KR100624583B1 (ko) 2006-09-15
NZ538138A (en) 2008-05-30
ECSP055597A (es) 2005-04-18
RU2005107317A (ru) 2005-10-10
RU2343919C2 (ru) 2009-01-20
AR040859A1 (es) 2005-04-20
IL166601A0 (en) 2006-01-15
NO20051232L (no) 2005-05-12
EP1534339A1 (de) 2005-06-01
BR0313462A (pt) 2005-07-05
JP2005537302A (ja) 2005-12-08
WO2004016289A1 (en) 2004-02-26
TW200410713A (en) 2004-07-01

Similar Documents

Publication Publication Date Title
IL166601A0 (en) Topical anhydrous and ethanol-free ascomycin compositions
FR2842417B1 (fr) Composition cosmetique
FR2842416B1 (fr) Composition cosmetique
HK1113083A1 (en) Topical composition
DE60016903D1 (de) Antiperspirant-zusammensetzungen
ITMI991754A0 (it) Composizioni cosmetiche
IL162606A0 (en) Topical compositions of urea
FR2831433B1 (fr) Composition topique solide
SI1513514T1 (sl) Topične formulacije hidroksimatairezinola
DE602004018512D1 (de) Stifte zusammensetzungen
ATE428420T1 (de) Substituierte 8-arylchinoline als phosphodiesterase-4-hemmer
DE60134758D1 (de) Schwimmbeckenabdeckung bestehend aus Profilen
NO20020685D0 (no) Topiske organiske ektoparasittiske formuleringer
ID29711A (id) Peralatan untuk mengadakan air-bersalin
DE60304501D1 (de) Rostschutzzusammensetzung
PT1526849E (pt) Formulacoes topicas contendo cetoprofeno estabilizado com sulisobenzona
FR2819176B1 (fr) Composition cosmetique pelable
NO20023157D0 (no) Flerledet höyspenningskabel
DE602004007221D1 (de) Schweisshemmende Zusammensetzungen
ATE451907T1 (de) Antiperspirans-spray-zusammensetzungen
FR2832057B1 (fr) Composition demaquillante
CY2003001I2 (el) Τοπικες συνθεσεις μακρολιδιων
FR2850276B1 (fr) Composition anti-exsudante et/ou anti-desquamante et/ou anti-exfoliante
GB0312474D0 (en) Topical composition
ITMI20020039A1 (it) Composizioni comprendenti colostro e loro uso

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties